BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
Nymox Pharmaceutical Corp (NQ: NYMX)
5.050 USD  +0.010 (+0.20%)
Streaming Delayed Price  /  Updated: 10:33 AM EDT, Apr 21, 2014  /  Add to My Watchlist      
(NYMX) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
April 21, 2014
(Stock Blog Hub, 7/13/12)
Nymox Pharmaceutical Corporation (NYMX) recently announced that it has completed enrollment of benign prostatic hyperplasia (BPH) patients in a phase III study (NX02-0020) of...(read more)
Nymox Pharmaceutical (NYMX) Company Overview

There is no analysis for NYMX yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here